Vimarsana
Biggest News Aggregation in the World

Page 11 - Truth Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Truth Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Truth Group Today - Breaking & Trending Today

ReShape Lifesciences Inc.: ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results - Vimarsana News

ReShape Lifesciences Inc.: ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results

ReShape Lifesciences Inc.: ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results Recent Highlights and Accomplishments Entered into a definitive merger agreement with Obalon Therapeutics, Inc., a company focused on developing and commercializing novel technologies for weight loss. Strategic merger provides market synergies and the opportunity for the combined company to trade on NASDAQ. Initiated enrollment of healthcare professionals in ReShapeCare , the Company's first-in-class reimbursed, telehealth-based coaching program providing patients a tailored, high-tou...

OrthoPediatrics Corp. Launches Dedicated ApiFix Website to Support Game-Changing Spinal ... - Vimarsana News

OrthoPediatrics Corp. Launches Dedicated ApiFix Website to Support Game-Changing Spinal ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. OrthoPediatrics Corp. Launches Dedicated ApiFix Website to Support Game-Changing Spinal ... OrthoPediatrics Corp.February 18, 2021 GMT WARSAW, Ind., Feb. 18, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics and which has expanded its operating reach over the last year to serve more children around the world, today announced the launch of APIFIX.COM, a new online pre...

Source: apnews.com
Number of Shares and Voting Rights of ADOCIA as of January 31, 2021 - Vimarsana News

Number of Shares and Voting Rights of ADOCIA as of January 31, 2021

Number of Shares and Voting Rights of ADOCIA as of January 31, 2021 Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers, or "AMF") charter ADOCIA SA (Paris:ADOC), a French société anonyme (corporation), 115, avenue Lacassagne, 69003 Lyon, (Euronext Paris: FR0011184241 ADOC) a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, releases its total number of outstanding shares as well a...

FOIA Request Results in Release of 'Dancing Israeli' Photographs – American Free Press - Vimarsana News

FOIA Request Results in Release of 'Dancing Israeli' Photographs – American Free Press

By Dave Gahary Although the fake news media has all but erased Israel’s involvement in the 9/11 false-flag terrorist attacks on New York City and Washington, a recent successful Freedom of Information Act (FOIA) request and eventual release of photographs of the so-called “Dancing Israelis”—who were caught celebrating while the Twin Towers burned—has reignited the discussion of the Zionist state’s central role in that event, which dramatically altered all Americans’ lives. Not that the mainstream media will pick up this story and run with it. Many readers of this newspaper will ...

Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases - Vimarsana News

Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases

Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases News provided by Share this article Share this article HOUSTON, Feb. 8, 2021 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the Agencja Badań Medycznych (The Medical Research Agency) a Polish state agency responsible for development of scientific research in the field of medi...